Why it was recalled
Presence of Particulate Matter: Glass particles were found in pellet vials.
Product description
TESTOSTERONE PELLET 200 mg BLUNT (with Cholesterol </=2%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0124-01
Lot numbers, UPCs & expiration codes
Lot 20250217@7, exp 1/31/2026
Where it was sold
Nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0414-2025
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Apr 28, 2025
- FDA report date
- May 14, 2025
- Quantity
- 355 vials
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- BSO LLC
Original FDA data
Every field from FDA enforcement report D-0414-2025, exactly as published.
Show all FDA fields
- City
- Lakewood
- State
- CO
- Status
- Ongoing
- Country
- United States
- Event ID
- 96792
- Address
- 12860 W Cedar Dr Ste 211
- Code information
- Lot 20250217@7, exp 1/31/2026
- Postal code
- 80228-1971
- Report date
- May 14, 2025
- Product type
- Drugs
- Recall number
- D-0414-2025
- Classification
- Class II
- Recalling firm
- BSO LLC
- Product quantity
- 355 vials
- Reason for recall
- Presence of Particulate Matter: Glass particles were found in pellet vials.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- TESTOSTERONE PELLET 200 mg BLUNT (with Cholesterol </=2%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0124-01
- Distribution pattern
- Nationwide in the USA
- Recall initiation date
- Apr 28, 2025
- Initial firm notification
- Letter
- Center classification date
- May 6, 2025